36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate Tablets
Condition: OsteoporosisIntervention: Drug: Sodium risedronateSponsor: TakedaActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2014 Category: Research Source Type: clinical trials
Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture
Condition: Hip FractureInterventions: Drug: Risedronate; Other: Nutritional supplement; Dietary Supplement: Calcium and vitamin D3Sponsor: Karolinska InstitutetCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2013 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women
Condition: OsteoporosisInterventions: Drug: Risedronate/Cholecalciferol combination(montly); Drug: Risedronate/Cholecalciferol combination(weekly)Sponsors: Hanlim Pharm. Co., Ltd.; Hanlim Pharm. Co., Ltd.Recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2013 Category: Research Source Type: clinical trials